As the experts in digestive and metabolic medicine and as a family-owned business with a global presence, we focus on developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis. The Development Program Lead (DPL) is responsible for the strategic and operational management of a development program from the early stages through to approval. The IDT consists of the following functions: Pre- & Early Clinical Research, Clinical Research, CMC Project Management, Global Safety, Global Medical, Global Commercial New Products, Global Market Access, Intellectual Property and Technical Operations. * The DPL implements project management standards, processes, and templates across all pre-clinical and clinical projects
mehr